Intercytex(英國)

Intercytex

英國Intercytex www.intercytex.comIntercytex市值約為1,050萬英鎊，該公司目前正在研發(fā)一種男性抗脫發(fā)藥物。Intercytexistheleadingdeveloperofinnovativeregenerativemedicineproducts.Intercytexusesitsfullyintegratedcelltechnologyplatformt odevelopliving,humancell-basedproducts,atcommerciallyviablescaleinattractivemarkets.Intercytexhasfourproductsindevelopment: VAVELTA®,askinrepairandrejuvenationproductintendedtoimprovethefeel,functionandappearanceofskindamagedbyscarringandtheagingprocess,commerciallyavailablefromanumberofaccreditedcentresintheUKSHEF-1,developmentofastemcelllinesuitablefordifferentiationintoretinalpigmentepithelial(RPE)cells,beingcarriedoutincollaborationwiththeLondonProjecttoCureBlindnessICX-SKN,beingdevelopedasaskingraftreplacementforburnsandacutewounds,PhaseItrialscompletedICX-TR